Charter 1: Triple Negative Breast Cancer

Back

Charter 1: Triple Negative Breast Cancer

16.25
The biology of new targets
Professor Andrew Tutt

16.45
Precision medicine for triple negative breast cancer patients using a systems biology approach
Dr Chuck Perou

17.05
Immunologic advances
Professor Giuseppe Curigliano

17.25
Selected Free Communication:
Comprehensive molecular characterisation of TNBCs expressing HORMAD1, a driver of homologous recombination deficiency
Mr Jelmar Quist, King’s College London

Chairs: Professor Andrew Tutt and Professor Ingunn Holen